Tremor
Methodology & AI Transparency ⓘ
Tremor Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is a tremor? A tremor is a neurological condition that includes shaking or trembling movements in one or more parts of your body.
- 2 Real-world patient consensus: Federal ICD-10-CM code R25.1 categorizes Tremor under Neurology, Stroke & Movement Disorders.
- 3 Typical cash cost range: Differential triage of Tremor (R25.1) utilizes CSF/autoimmune antibody panels in Tremor (R25.1: when indicated).
- 4 Top reported side effects / signs: Key Brain & Neurology biomarkers for Tremor (R25.1): Carotid Duplex / in Tremor (R25.1: Cerebral Perfusion) & HbA1c & Blood in Tremor (R25.1: Pressure Neuro-Targets) (BP < 120/75 mmHg; HbA1c < 5.7% (R25.1)).
Ask our AI Specialists anything about Tremor
What Is Tremor?
What is a tremor? A tremor is a neurological condition that includes shaking or trembling movements in one or more parts of your body. It most often affects the hands. But it can also affect the arms, legs, head, vocal cords, and torso (trunk). A tremor is involuntary, meaning that you cannot control it. It happens because of muscle contractions. A tremor may come and go, or it may be constant. It can happen on its own or be caused by another disorder. It is not life threatening, but it may cause challenges. It can make it hard to do daily life tasks such as writing, typing, eating, and dressing. In some cases, a tremor can even lead to disabilities .
Pathophysiology, Underlying Causes & Clinical Presentation
Tremor (R25.1) alters brain & neurology homeostasis through cerebrovascular ischemia [Tremor R25.1]; Cross-referenced with NIH MeSH (Tremor), clinical remission targets HbA1c & Blood in Tremor (R25.1: Pressure Neuro-Targets) within BP < 120/75 mmHg; HbA1c < 5.7% (R25.1).
Common Symptoms & Clinical Signs
- • Neurologic disorders, including multiple sclerosis , Parkinson's disease, stroke , and traumatic brain injury
- • Alcohol use disorder (AUD) or alcohol withdrawal
- • Presentation of Tremor (R25.1): focal motor weakness, in Tremor (R25.1: resting or action)
- • Secondary Tremor clinical sign: episodic vertigo, imbalance, in Tremor (R25.1: coordination drift, or)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Tremor Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R25.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Neurology, Stroke & Movement Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Carotid Duplex / in Tremor (R25.1: Cerebral Perfusion) | No hemodynamically significant stenosis (R25.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Blood in Tremor (R25.1: Pressure Neuro-Targets) | BP < 120/75 mmHg; HbA1c < 5.7% (R25.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Tremor (R25.1: & Methylmalonic Acid) | B12 > 500 pg/mL; MMA < 240 nmol/L (R25.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Tremor
Treatment selection for Tremor depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tremor)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Tenecteplase versus standard care for minor ischaemic stroke according to the Of 881 patients, complete occlusion was present in 218 in the control and 216 in the tenecteplase arm, near occlusion in 102 and 92 and no visible occlusion in 130 and 123, respectively. European stroke journal • 2026-09-05 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 42734928 ↗ |
| Can This Approach Help? Inside the Latest Research on Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition In the POINT trial population, prior treatment with statin was marginally associated with decreased odds of early recurrence of stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association • 2025-07-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 40381866 ↗ |
Tremor Patient Community & “People Like Me” Threads
Filter Tremor community threads and patient logs by age, biological sex, dosage, and treatment duration.